Chlorotoxin

DB15210InvestigationalProtein Based Therapies

Chlorotoxin is under investigation in clinical trial NCT00733798 (A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma).

Mechanism: Pharmacologically active on 72 kDa type IV collagenase, Annexin A2, and H(+)/Cl(-) exchange transporter 3
Curator reviewed
Also known as: TM 601 · TM-601 · TM601 peptide

Resolves to

Compound

UNII06UV5RFW57CAS163515-35-3

Targets

P08253MMP2P07355ANXA2P51790CLCN3

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Chlorotoxin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account